▁ 4.1171875
8 3.853515625
% 6.42578125
▁of 1.068359375
▁the 2.35546875
▁residents 6.44921875
▁of 0.7275390625
▁progress 12.5859375
ive 0.044586181640625
▁countries 6.5625
▁have 2.390625
▁chron 5.88671875
ic 0.01953125
▁pain 1.9951171875
, 1.76171875
▁which 2.646484375
▁is 0.72412109375
▁considered 4.58203125
▁to 1.259765625
▁be 0.04473876953125
▁an 2.578125
▁extreme 5.44140625
▁issue 5.27734375
. 0.92724609375
<0x0A> 1.5771484375
There 3.8359375
▁is 1.6396484375
▁currently 5.0078125
▁a 1.8984375
▁severe 4.375
▁lack 1.720703125
▁of 0.0312042236328125
▁information 3.09765625
▁about 1.548828125
▁the 0.9990234375
▁effects 3.814453125
▁of 0.1434326171875
▁op 3.953125
i 3.328125
ates 0.0115814208984375
. 2.69140625
▁They 4.21484375
▁manage 8.6328125
▁pain 2.408203125
▁successfully 6.05859375
, 0.86328125
▁but 0.27685546875
▁the 2.6015625
▁past 9.1640625
▁few 1.2783203125
▁dec 1.498046875
ades 1.895427703857422e-05
▁indicated 8.4140625
▁the 2.53125
▁growing 3.900390625
▁concern 3.1796875
▁regarding 2.7578125
▁op 2.083984375
iate 0.74267578125
▁ab 1.486328125
use 0.0109710693359375
▁in 3.48046875
▁forms 9.5859375
▁of 0.22705078125
▁over 3.1796875
d 0.1207275390625
ose 0.322509765625
▁and 0.826171875
▁add 0.56884765625
iction 0.0161590576171875
. 0.106689453125
▁A 4.6015625
▁more 5.609375
▁manage 8.5546875
able 0.0025787353515625
▁and 2.2890625
▁sa 2.255859375
fer 8.416175842285156e-05
▁alternative 1.5380859375
▁might 5.4609375
▁be 0.18408203125
▁medical 4.72265625
▁mar 0.68017578125
iju 0.0011701583862304688
ana 4.9233436584472656e-05
. 0.57861328125
▁However 4.859375
, 0.0113677978515625
▁the 1.8046875
▁legal 3.599609375
▁status 1.18359375
▁and 3.513671875
▁novel 10.4921875
ty 0.1849365234375
▁of 0.16064453125
▁this 1.806640625
▁drug 2.103515625
▁do 4.7578125
▁not 0.02642822265625
▁allow 0.8916015625
▁finding 7.26953125
▁a 2.486328125
▁large 3.638671875
▁number 0.8388671875
▁of 0.0029430389404296875
▁studies 1.0087890625
▁on 1.744140625
▁its 1.041015625
▁effect 1.974609375
iveness 0.158447265625
. 0.6708984375
▁Specifically 9.1640625
, 0.11004638671875
▁it 2.82421875
▁concerns 5.28125
▁the 1.0341796875
▁emot 9.6875
ional 0.0284271240234375
▁condition 5.26953125
▁of 0.6240234375
▁patients 1.076171875
▁experien 5.71875
cing 3.4570693969726562e-06
▁chron 0.335205078125
ic 0.0002644062042236328
▁pain 0.02764892578125
. 0.3056640625
▁This 3.544921875
▁research 2.62109375
▁paper 2.482421875
▁a 1.5390625
ims 0.0002911090850830078
▁to 0.1435546875
▁analyze 2.712890625
▁levels 10.6328125
▁of 0.03656005859375
▁de 1.8828125
pression 0.048980712890625
▁and 0.6494140625
▁anx 0.12353515625
iety 0.0002739429473876953
▁among 1.4326171875
▁people 2.357421875
▁receiving 4.52734375
▁ther 5.03515625
apy 0.035003662109375
▁by 4.578125
▁comparing 10.421875
▁the 1.873046875
▁effects 2.978515625
▁of 0.03521728515625
▁ph 5.20703125
arma 0.416259765625
ce 0.01288604736328125
ut 0.00017595291137695312
ical 0.017333984375
▁op 2.048828125
io 2.54296875
ids 0.08319091796875
▁and 0.470703125
▁MM 3.953125
. 2.23046875
<0x0A> 0.30517578125
The 1.34765625
▁study 2.083984375
▁was 1.3291015625
▁conducted 0.54443359375
▁in 1.23046875
▁the 1.6142578125
▁form 2.9140625
▁of 0.002475738525390625
▁collection 11.09375
▁and 0.8388671875
▁analysis 0.342529296875
▁of 0.00859832763671875
▁statistical 3.845703125
▁data 0.10968017578125
. 1.0380859375
▁Part 5.234375
icip 0.23681640625
ants 0.057342529296875
▁were 0.58447265625
▁rec 3.80859375
ru 0.0010690689086914062
ited 0.0001938343048095703
▁for 4.2109375
▁six 6.5625
▁months 0.55615234375
▁at 3.80078125
▁two 2.775390625
▁major 4.33984375
▁pain 2.900390625
▁relief 5.078125
▁cent 0.7802734375
ers 0.05853271484375
▁in 0.57275390625
▁Israel 4.87890625
. 0.417724609375
▁The 1.4345703125
▁research 2.822265625
ers 0.9765625
▁used 2.263671875
▁The 6.90234375
▁De 3.099609375
pression 0.02435302734375
▁Module 7.28515625
▁of 0.70263671875
▁the 0.2332763671875
▁Pat 2.958984375
ient 0.00799560546875
▁Health 0.0307769775390625
▁Question 0.017486572265625
naire 0.027008056640625
▁and 2.404296875
▁the 0.765625
▁General 1.1982421875
ized 0.669921875
▁An 0.00432586669921875
x 8.273124694824219e-05
iety 0.00046515464782714844
▁Dis 0.1317138671875
order 0.020233154296875
▁Sc 1.4130859375
ale 0.0030918121337890625
▁to 0.8369140625
▁interview 7.85546875
▁participants 2.71875
, 3.966796875
▁evaluate 5.06640625
▁their 0.5380859375
▁answers 4.33203125
, 0.42236328125
▁and 0.04058837890625
▁conduct 5.20703125
▁the 1.80078125
▁study 2.546875
. 0.08984375
▁To 4.8359375
▁specifically 9.7578125
▁evaluate 2.99609375
▁and 5.37890625
▁compare 0.53173828125
▁the 0.431396484375
▁prob 10.9921875
abilities 0.09014892578125
▁of 0.08636474609375
▁de 0.96728515625
pression 0.0594482421875
▁or 4.109375
▁anx 0.04998779296875
iety 0.0005369186401367188
▁among 1.5283203125
▁the 1.9189453125
▁diverse 9.65625
▁groups 0.66015625
, 0.734375
▁the 0.54541015625
▁study 3.13671875
▁used 1.2431640625
▁multiple 5.3984375
▁log 0.47509765625
istic 0.026580810546875
▁regression 0.2880859375
▁analysis 1.3408203125
▁and 2.9453125
▁chose 8.71875
▁medical 6.3515625
▁mar 0.08709716796875
iju 0.00098419189453125
ana 2.300739288330078e-05
▁as 0.6171875
▁the 0.85009765625
▁control 3.263671875
▁group 0.7607421875
. 0.268310546875
<0x0A> 0.43212890625
The 0.77880859375
▁most 5.58203125
▁reve 5.85546875
aling 0.0007085800170898438
▁and 2.87109375
▁inclus 10.828125
ive 0.0034542083740234375
▁type 8.015625
▁of 0.00762176513671875
▁study 3.228515625
▁is 1.6435546875
▁the 1.396484375
▁one 1.328125
▁that 0.9501953125
▁contains 4.28515625
▁direct 6.1484375
▁responses 6.98828125
▁from 0.55126953125
▁a 3.380859375
▁large 0.8759765625
▁number 0.46142578125
▁of 0.002971649169921875
▁participants 0.7685546875
. 0.34619140625
<0x0A> 4.55859375
The 0.89208984375
▁analysis 3.890625
▁of 0.92724609375
▁any 9.2734375
▁human 6.9140625
▁reaction 4.6015625
▁has 4.7421875
▁a 1.8369140625
▁high 2.80078125
▁potential 3.216796875
▁of 1.3828125
▁subject 3.05859375
iveness 3.623046875
▁and 1.4580078125
▁bias 1.603515625
, 1.6904296875
▁especially 2.224609375
▁regarding 4.015625
▁people 4.85546875
▁in 3.6796875
▁severe 3.19921875
▁pain 0.5107421875
▁and 2.58984375
▁un 5.96484375
stable 1.0224609375
▁emot 1.0205078125
ional 0.07916259765625
▁condition 1.6376953125
. 0.07904052734375
▁Perhaps 9.125
▁some 5.59375
▁patients 2.25390625
▁tend 4.859375
▁to 0.01096343994140625
▁ex 2.345703125
agger 0.00991058349609375
ate 0.0012674331665039062
▁their 0.87890625
▁de 2.9921875
press 2.044921875
ive 0.07220458984375
▁state 2.5
▁or 1.7939453125
▁vice 5.54296875
▁vers 0.036773681640625
a 6.115436553955078e-05
, 1.0751953125
▁de 7.49609375
- 2.38671875
emph 0.370849609375
as 0.0027332305908203125
ize 0.06951904296875
▁serious 7.0234375
▁difficulties 6.25
. 0.80224609375
▁Because 6.60546875
▁the 2.783203125
▁survey 4.9140625
▁responses 6.140625
▁were 1.2119140625
▁thoroughly 9.171875
▁anonymous 2.560546875
, 0.214599609375
▁the 1.0380859375
▁research 1.0263671875
ers 0.09466552734375
▁were 2.224609375
▁unable 2.73046875
▁to 0.0014743804931640625
▁carefully 7.49609375
▁analyze 2.46875
▁each 2.478515625
▁patient 2.439453125
’ 0.78271484375
s 0.0011749267578125
▁reaction 3.966796875
▁and 1.345703125
▁compare 3.51171875
▁it 0.8193359375
▁to 0.5048828125
▁the 0.9140625
▁actual 4.4296875
▁states 8.1171875
▁of 0.50390625
▁condition 7.02734375
. 0.40380859375
▁More 6.5078125
▁accurate 3.23828125
▁answers 4.40234375
▁could 1.6689453125
▁be 0.64794921875
▁obtained 0.98974609375
▁by 1.3759765625
▁professional 6.02734375
▁psych 1.3271484375
olog 0.38330078125
ists 0.0016317367553710938
▁via 7.2890625
▁personal 2.791015625
▁communication 4.62109375
▁and 2.138671875
▁behavior 6.16796875
al 0.330078125
▁analysis 1.7890625
. 0.30810546875
▁However 3.232421875
, 0.0009126663208007812
▁this 1.474609375
▁method 2.41015625
▁of 2.232421875
▁research 1.5859375
▁is 1.1845703125
▁way 5.97265625
▁more 0.953125
▁resource 4.67578125
- 0.3515625
int 1.4814453125
ensive 0.0323486328125
▁and 0.45849609375
▁energy 11.1015625
- 0.106689453125
consum 0.3837890625
ing 0.001678466796875
. 0.80322265625
<0x0A> 0.59912109375
Part 5.57421875
icip 0.267578125
ants 0.1392822265625
▁were 1.3369140625
▁rec 1.9775390625
ru 0.0006208419799804688
ited 0.00013518333435058594
▁for 1.16015625
▁six 0.2484130859375
▁months 0.0037593841552734375
▁at 0.3154296875
▁two 0.034576416015625
▁major 0.03265380859375
▁pain 0.01544189453125
▁relief 0.0086669921875
▁cent 0.00455474853515625
ers 0.0005812644958496094
▁in 0.0307159423828125
▁Israel 0.004085540771484375
. 0.1265869140625
▁All 6.53125
▁patients 1.9833984375
▁experienced 4.5078125
▁chron 0.61572265625
ic 0.00016760826110839844
▁pain 0.1097412109375
▁for 2.2265625
▁at 0.88330078125
▁least 0.0024261474609375
▁ 1.71875
3 1.3916015625
▁months 0.1468505859375
. 1.0654296875
▁The 1.6572265625
▁study 1.6865234375
▁included 1.5517578125
▁ 0.5517578125
8 2.978515625
9 2.388671875
0 3.05859375
▁participants 1.638671875
, 1.3525390625
▁of 2.673828125
▁which 0.339599609375
▁ 0.10101318359375
4 1.5419921875
7 2.5
4 2.609375
▁( 3.087890625
5 0.10076904296875
9 4.921875
%) 0.6630859375
▁were 0.86865234375
▁treated 2.88671875
▁sole 6.484375
ly 0.0001271963119506836
▁with 0.314208984375
▁op 1.05078125
io 0.5703125
ids 0.1292724609375
, 0.5068359375
▁ 0.65966796875
3 1.2998046875
2 2.244140625
9 2.494140625
▁( 0.048248291015625
4 2.515625
1 1.337890625
%) 0.051300048828125
▁were 1.4423828125
▁treated 0.44189453125
▁with 0.39697265625
▁MM 1.0771484375
, 0.387451171875
▁and 0.109619140625
▁ 0.18212890625
7 2.03125
7 2.509765625
▁( 0.11700439453125
8 1.9296875
. 1.0341796875
6 2.349609375
%) 0.0670166015625
▁acquired 10.5234375
▁both 0.63134765625
▁( 5.125
Fe 10.6484375
ing 1.1875
old 0.235595703125
▁et 0.91943359375
▁al 0.0267333984375
., 0.2093505859375
▁ 0.0116424560546875
2 0.007266998291015625
0 0.0004267692565917969
1 0.115966796875
7 1.4990234375
). 0.037811279296875
▁The 1.623046875
▁remaining 7.5234375
▁ten 6.75390625
▁participants 1.2421875
▁who 4.87890625
▁did 2.4765625
▁not 0.007415771484375
▁receive 2.322265625
▁ph 4.828125
arma 0.1627197265625
ce 0.0028076171875
ut 9.5367431640625e-07
ical 0.0033416748046875
▁op 2.341796875
io 0.1800537109375
ids 0.05706787109375
▁and 3.0078125
▁medical 2.447265625
▁mar 0.07586669921875
iju 0.00026869773864746094
ana 3.5881996154785156e-05
▁were 0.467041015625
▁with 6.921875
dra 0.061004638671875
wn 1.3113021850585938e-05
▁from 0.1998291015625
▁the 0.181396484375
▁analysis 2.162109375
▁in 5.07421875
▁the 1.2802734375
▁research 4.4453125
. 1.349609375
▁Therefore 5.0625
, 0.00855255126953125
▁it 4.14453125
▁is 1.0615234375
▁not 2.873046875
▁possible 0.74853515625
▁to 0.005558013916015625
▁compreh 5.76171875
ens 0.0882568359375
ively 0.01837158203125
▁compare 1.404296875
▁patients 4.8046875
▁taking 4.0625
▁medic 4.51953125
ations 0.8125
▁with 1.46875
▁those 1.380859375
▁who 0.728515625
▁do 1.376953125
▁not 0.0045166015625
. 0.552734375
<0x0A> 0.591796875
The 0.865234375
▁study 1.505859375
▁looked 7.24609375
▁at 0.387451171875
▁the 0.94775390625
▁inter 6.47265625
dep 3.26953125
end 0.00028133392333984375
ence 0.00823211669921875
▁of 0.5732421875
▁various 3.978515625
▁factors 0.693359375
▁that 1.865234375
▁affected 4.20703125
▁the 0.5
▁physical 6.5234375
▁and 0.272705078125
▁emot 0.46875
ional 0.0001163482666015625
▁condition 1.443359375
▁of 0.0577392578125
▁patients 0.79345703125
. 0.68505859375
<0x0A> 3.0703125
The 0.91455078125
▁question 5.83203125
na 1.0390625
ires 3.254413604736328e-05
▁used 1.990234375
▁different 7.73046875
▁variable 8.5859375
▁measures 4.16015625
▁to 1.5439453125
▁collect 3.466796875
▁information 1.705078125
. 1.4619140625
▁For 2.173828125
▁example 0.4248046875
, 0.003780364990234375
▁it 4.640625
▁included 1.8837890625
▁compreh 8.6171875
ensive 0.0401611328125
▁so 5.6640625
cio 0.000507354736328125
- 0.44873046875
dem 0.1568603515625
ographic 0.06842041015625
▁data 0.791015625
: 4.55078125
▁gender 1.955078125
, 0.053314208984375
▁age 0.246337890625
, 0.0262298583984375
▁country 4.1796875
, 2.59375
▁type 4.13671875
▁of 0.08477783203125
▁residence 4.04296875
▁( 2.095703125
urban 0.7919921875
/ 1.5048828125
r 0.1553955078125
ural 0.00121307373046875
), 0.2149658203125
▁years 5.875
▁of 0.180908203125
▁education 0.619140625
, 0.1090087890625
▁and 1.3505859375
▁employ 2.1328125
ment 0.00151824951171875
▁status 0.6318359375
. 0.1728515625
▁Pat 4.80859375
ients 0.127685546875
▁were 1.029296875
▁also 0.7294921875
▁asked 0.4951171875
▁about 0.826171875
▁their 0.7578125
▁medical 2.404296875
▁history 0.390380859375
▁over 8.6328125
▁the 0.06317138671875
▁years 4.56640625
▁and 1.7802734375
▁the 1.55078125
▁current 2.99609375
▁presence 5.41796875
▁of 0.0897216796875
▁any 2.193359375
▁severe 3.919921875
▁dise 1.9267578125
ases 7.641315460205078e-05
▁such 3.982421875
▁as 0.0013837814331054688
▁heart 2.67578125
▁failure 1.7158203125
, 0.3076171875
▁di 1.63671875
ab 0.0007963180541992188
etes 0.0020599365234375
, 0.07373046875
▁ar 4.2890625
th 0.172607421875
rit 0.020904541015625
is 0.0041961669921875
, 0.0302581787109375
▁and 1.419921875
▁so 2.314453125
▁on 0.1363525390625
. 0.057373046875
▁The 1.609375
▁third 6.51953125
▁measure 4.13671875
▁of 2.197265625
▁the 0.830078125
▁question 1.9404296875
naire 0.20849609375
▁was 0.86328125
▁indicated 11.078125
▁by 1.1787109375
▁information 6.86328125
▁on 2.05859375
▁any 5.42578125
▁twelve 14.0703125
- 0.264404296875
month 0.1876220703125
▁and 4.87890625
▁lifetime 0.88037109375
▁drug 2.97265625
▁and 1.7138671875
▁alco 0.1324462890625
hol 5.829334259033203e-05
▁consumption 4.265625
. 0.472412109375
▁In 3.525390625
▁addition 0.744140625
, 0.270263671875
▁the 0.81787109375
▁record 10.2890625
▁included 1.283203125
▁a 2.890625
▁pain 4.51171875
▁measurement 4.88671875
▁scale 0.85498046875
▁from 4.15234375
▁ 0.481201171875
0 0.283935546875
▁to 0.236083984375
▁ 0.005016326904296875
1 0.06903076171875
0 0.0341796875
▁to 3.37109375
▁evaluate 1.4697265625
▁dis 6.08203125
com 0.09869384765625
fort 0.0004067420959472656
▁feelings 8.3125
▁during 4.27734375
▁the 0.205810546875
▁last 0.9541015625
▁month 1.779296875
. 0.2646484375
<0x0A> 0.77587890625
Am 5.71875
ong 0.005001068115234375
▁all 2.3046875
▁participants 2.27734375
▁in 3.953125
▁the 0.1358642578125
▁study 0.3232421875
, 0.038055419921875
▁ 0.78125
4 1.90625
2 2.31640625
. 1.1650390625
2 2.25
% 0.059234619140625
▁suffered 3.708984375
▁from 0.05706787109375
▁de 1.1171875
pression 0.1435546875
, 0.734375
▁and 1.1064453125
▁ 0.1099853515625
3 1.3681640625
7 2.349609375
% 2.58203125
▁experienced 2.13671875
▁excess 6.671875
ive 0.02618408203125
▁anx 0.1842041015625
iety 0.0009336471557617188
. 0.4130859375
▁The 1.67578125
▁pl 11.2109375
ur 0.51416015625
ality 0.0006480216979980469
▁of 0.1343994140625
▁de 2.576171875
press 1.4306640625
ive 0.036529541015625
▁dis 3.423828125
orders 0.14501953125
▁among 3.095703125
▁patients 0.9033203125
▁in 4.125
▁the 1.23046875
▁op 2.552734375
i 2.95703125
ates 0.0245513916015625
, 8.140625
▁medical 2.2734375
▁mar 0.037567138671875
iju 0.0007886886596679688
ana 1.9788742065429688e-05
, 0.10565185546875
▁and 0.05218505859375
▁mixed 1.5390625
▁OP 12.078125
MM 3.974609375
▁groups 0.55126953125
▁number 9.3046875
ed 0.0185546875
▁ 0.17724609375
5 2.236328125
7 2.798828125
. 0.6103515625
1 2.521484375
%, 0.2379150390625
▁ 0.003910064697265625
2 2.578125
2 2.728515625
. 0.11517333984375
3 2.265625
%, 0.04974365234375
▁and 0.059906005859375
▁ 0.0016851425170898438
5 2.01171875
1 2.06640625
. 0.16943359375
4 1.861328125
%, 0.1605224609375
▁respectively 0.0269775390625
. 0.253662109375
▁The 1.26953125
▁pl 3.5625
ur 0.01061248779296875
ality 2.372264862060547e-05
▁of 0.0285186767578125
▁anx 0.40869140625
iety 0.0200042724609375
▁contained 10.4140625
▁ 0.229248046875
4 1.1376953125
8 2.376953125
. 0.173583984375
4 2.197265625
% 1.875
▁among 2.712890625
▁OP 4.3046875
▁patients 6.796875
, 0.2213134765625
▁ 0.06744384765625
2 0.97998046875
1 2.439453125
. 0.1156005859375
5 2.11328125
% 0.022857666015625
▁among 0.441650390625
▁MM 0.09356689453125
▁patients 0.53466796875
, 0.020904541015625
▁and 0.014434814453125
▁ 0.02490234375
3 1.373046875
8 1.8974609375
. 0.1207275390625
7 2.228515625
% 0.01052093505859375
▁among 0.224853515625
▁OP 2.01953125
MM 0.118408203125
▁participants 2.970703125
. 0.198486328125
▁Pat 5.46875
ients 0.0218353271484375
▁who 1.4150390625
▁took 2.42578125
▁strong 10.2890625
▁op 0.634765625
i 0.80615234375
ates 0.00395965576171875
▁were 1.6650390625
▁t 9.9296875
ended 0.8681640625
▁to 0.006908416748046875
▁place 10.171875
▁their 2.400390625
▁pain 1.548828125
▁on 1.85546875
▁a 0.65625
▁scale 1.91015625
▁of 0.386962890625
▁ 0.1002197265625
9 2.650390625
▁to 2.439453125
▁ 0.0103302001953125
1 0.007015228271484375
0 0.007232666015625
▁( 2.591796875
Fe 2.228515625
ing 0.003124237060546875
old 0.0004715919494628906
▁et 0.01424407958984375
▁al 0.001232147216796875
., 0.0124664306640625
▁ 0.00135040283203125
2 0.0002677440643310547
0 3.147125244140625e-05
1 0.0007967948913574219
7 0.00594329833984375
). 0.0156402587890625
▁They 4.87109375
▁were 1.8466796875
▁also 0.740234375
▁an 9.1796875
gu 4.8515625
ished 0.0751953125
▁em 5.5625
otion 0.0003361701965332031
ally 0.0006775856018066406
▁and 1.453125
▁react 7.328125
ed 0.0216064453125
▁rad 9.4296875
ically 0.0008268356323242188
▁neg 5.12109375
atively 0.0011434555053710938
▁to 0.1812744140625
▁almost 5.5
▁all 1.4619140625
▁survey 3.8671875
▁questions 0.227294921875
. 0.356689453125
▁Pat 3.259765625
ients 0.00603485107421875
▁who 0.826171875
▁took 1.7978515625
▁only 4.26953125
▁MM 0.50634765625
▁or 2.73046875
▁mixed 2.505859375
▁medic 1.736328125
ations 0.25390625
▁course 13.90625
▁had 2.390625
▁a 1.41796875
▁significantly 2.7734375
▁more 3.271484375
▁stable 2.453125
▁emot 0.90234375
ional 0.0013036727905273438
▁state 0.63330078125
▁and 1.24609375
▁cop 6.98046875
ed 0.0259552001953125
▁with 0.368408203125
▁pain 0.8759765625
▁more 1.8984375
▁manage 6.7890625
able 1.4189453125
. 0.3759765625
<0x0A> 0.47021484375
One 5.11328125
▁of 0.256103515625
▁the 0.004238128662109375
▁major 2.978515625
▁limitations 2.96875
▁is 2.908203125
▁the 0.495361328125
▁ins 4.91796875
u 0.0731201171875
fficient 0.0919189453125
ly 3.275390625
▁high 3.20703125
▁response 3.345703125
▁rate 0.10400390625
, 2.45703125
▁ 4.68359375
5 1.7236328125
7 2.953125
% 1.9619140625
▁instead 6.17578125
▁of 0.0029697418212890625
▁ 0.478271484375
7 2.060546875
0 0.52490234375
% 1.35546875
▁( 2.25
Fe 0.63427734375
ing 0.0017881393432617188
old 0.0003490447998046875
▁et 0.00823974609375
▁al 0.0002434253692626953
., 0.007694244384765625
▁ 0.0018815994262695312
2 0.00011301040649414062
0 4.947185516357422e-05
1 0.00041937828063964844
7 0.0033245086669921875
). 0.01500701904296875
▁It 2.501953125
▁can 3.107421875
▁be 0.62646484375
▁fairly 8.0625
▁explained 2.107421875
▁by 0.2216796875
▁the 0.28271484375
▁weak 7.4453125
▁focus 6.7734375
▁of 0.66943359375
▁respond 5.640625
ents 0.140380859375
▁who 3.4375
▁have 3.8203125
▁overcome 8.234375
▁severe 2.08984375
▁pain 0.638671875
▁sens 7.19921875
ations 0.267578125
▁and 0.9013671875
▁de 4.8125
press 0.74755859375
ive 0.038604736328125
▁episodes 2.5078125
. 0.59130859375
▁It 2.9375
▁is 0.6259765625
▁not 2.494140625
▁clear 3.572265625
▁how 1.830078125
▁to 3.5703125
▁use 5.296875
▁these 2.689453125
▁statistics 3.421875
, 3.201171875
▁as 1.296875
▁they 1.94140625
▁still 5.48828125
▁may 4.57421875
▁be 1.2392578125
▁relevant 5.9453125
▁for 1.763671875
▁the 1.755859375
▁overall 4.46484375
▁analysis 3.068359375
. 0.88623046875
